50 likes | 163 Views
European Prostate Cancer Therapeutics Market. “The European Market for Prostate Cancer Therapeutics is largely underdeveloped. It is constantly changing, offering industry participants many new market opportunities.”. Key features.
E N D
European Prostate Cancer Therapeutics Market “The European Market for Prostate Cancer Therapeutics is largely underdeveloped. It is constantly changing, offering industry participants many new market opportunities.”
Key features • Quality Analysis of the European LHRH and Anti-Androgen Therapeutics Market • The most in depth Analysis available of the European Brachytherapy Seeds Market • Coverage of Emerging Therapies • Strong Focus on Market Challenges & Strategies VOICE OVER TIPS • make sure the bullet points stand up on their own • raise the most salient points and talk knowledgably around each one! • Target time 30 - 40 seconds
Key content: Revenue Forecasts & Competitive Analysis Market Share Analysis- European & Country Levels Market Size and Forecast Segmentation: LHRH Analogs, Anti-Androgens Brachytherapy Seeds
Featured Companies • AstraZeneca • Takeda • Ipsen Biotech • Schering Ag • Amersham Health
What to do next For more information Call 44 20 7343 8342 or email enquiries@fs-europe.com Prostate Cancer Therapeutics is part of the Global Oncology Subscription www.pharma.frost.com